GlaxoSmithKline S.A.E. (BIOC.CA)

Also known as:  GSK Egypt, GlaxoSmithKline Egypt
Data delayed by 15 minutes
20.31 EGP -2.22-9.854%
As of 25 OCT 2021 12:25 GMT|Egypt SE

GSK Egypt Stock Price & Performance Powered By Knowledge Direct

Recommendation
-
Div Yield
1.579%
P/E (Last 12 Month)
0.0
Upside
-
Target Price (Mean)
-
52Wk
16.06 14 JAN
44.9 07 FEB

Open
23.75 EGP
Previous Close
22.53 EGP
Turnover
511.44K EGP
EPS
-
Volume
24,930
Transactions
97
Market Cap
1.88B EGP
IPO Date
01-Sep-1993
Analyst Recommendation
Sell
Hold
Buy
Analyst Rating
Strong Buy
Buy
Hold
Sell
Strong Sell

About GlaxoSmithKline S.A.E.

Country of Incorporation
Established In
1981
Primary Sector
Stock Listing
IDStock TypeCurrencyExchangeSymbol
BIOC.CASEOrdinaryEGPEgypt SEBIOC

Contact details

Primary address
Building: Boomerang Building 46, Block J
Street: Ninety Street
Floor: 1st-3rd Floor
Area: 5th Settlement
P.O. Box: 41
Country: Egypt
City: Cairo
City Suffix: 11835
CONTACT
    Region
    Cairo
    More
    All Health Care News
    All Markets News

    Ownership

    Revenue
    Net Income
    Profit Margin
    Total Assets
    Total Liabilities
    Debt to Assets
    Operating
    Investing
    Financing

    Company information provided by Refinitiv

    Refinitiv research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).

    Peers

    StocksLast Price% Change
    MEDICAL PACK0.386 EGP-3.258
    CLEOPATRA HOSP4.500 EGP5.634
    EGYPT INTL PHRM42.000 EGP-0.498
    CAIRO PHARMAC.39.000 EGP-2.50
    MINAPHARM PHARMA102.040 EGP-1.487
    ALX. PHARMACEUT.143.010 EGP-6.791
    More
    More

    Most Viewed Stocks

    Stock Screener

    More